Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03967223
Title Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors (IGNYTE-ESO)
Acronym IGNYTE-ESO
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Adaptimmune
Indications
Therapies
Age Groups: senior | child | adult
Covered Countries USA | NLD | ITA | GBR | FRA | ESP | CAN

Facility Status City State Zip Country Details
City of Hope National Medical Center Duarte California 91010 United States Details
Stanford Hospital and Clinics Stanford California 94305 United States Details
Sarah Cannon Research Institute Denver Colorado 80218 United States Details
Mayo Clinic Jacksonville Jacksonville Florida 32224 United States Details
University of Chicago Chicago Illinois 60637 United States Details
University of Iowa College of Medicine Iowa City Iowa 52242-1009 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02114 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
University of Michigan Medical Center Ann Arbor Michigan 48109 United States Details
Minnesota Oncology Hematology Minneapolis Minnesota 55455 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering cancer center New York New York 10065 United States Details
Duke University Medical Center Durham North Carolina 27710 United States Details
Ohio State University-Columbus Columbus Ohio 43210 United States Details
Oregon Health and Science University Portland Oregon 97239 United States Details
University of Pittsburgh, Hillman Cancer Centre Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
University Of Texas Southwestern Medical Center Dallas Texas 75390-8565 United States Details
University of Texas Southwestern Medical Center Dallas Texas 75390-9063 United States Details
University of Utah Salt Lake City Utah 84112 United States Details
Virginia Commonwealth University Richmond Virginia 23298 United States Details
Fred Hutchinson Cancer Research Seattle Washington 98109-1024 United States Details
Froedtert Hospital Milwaukee Wisconsin 53226 United States Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
CIUSSS de L'Est-De-Lile-De-Montreal Montreal Quebec H1T 2M4 Canada Details
Centre Léon Bérard Lyon cedex 08 69373 France Details
CHU de Bordeaux GH Sud Hôpital Haut Lévêque Pessac cedex 33604 France Details
Fondazione IRCCS Instituto Nazionale Dei Tumori Milano Lombardia 20133 Italy Details
Ircss Istituto Clinico Humanitas Rozzano (MI) Lombardia 20089 Italy Details
The Netherlands Cancer Institute Amsterdam 1066 CX Netherlands Details
Hospital Santa Creu Y Sant Pau Barcelona 08025 Spain Details
Ico Duran y Reynals l'Hospitalet de Llobrega Hospitalet de Llobregat, Barcelona 08907 Spain Details
Hospital Universitario Fundación Jiménez Díaz Madrid 28040 Spain Details
Hospital Virgen Del Rocio Sevilla 41013 Spain Details
Royal Marsden Hospital London SW3 6JJ United Kingdom Details
University College Hospital-London London WC1E 6AG United Kingdom Details
Christie Hospital NHS Foundation Trust Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field